[A case of sarcoidosis with cranial mononeuritis multiplex and peripheral polyneuropathy].
A 67-year-old woman with sarcoidosis, cranial mononeuritis multiplex and peripheral neuropathy was reported. The initial presentation of her sarcoidosis was a subcutaneous nodule of left knee joint on June, 1990. The number of subcutaneous nodules increased. Sarcoidosis was diagnosed by biopsy of the subcutaneous nodule. Paresthesia of the face and limbs appeared from November, 1991 and one month later, left abducens palsy and hearing disturbances were added. Alternate day therapy of 20mg prednisolone was effective in improvement of symptoms. The case of sarcoidosis with cranial mononeuritis multiplex and peripheral polyneuropathy was rarely found in 6 to 25% of patients with sarcoid neuropathy in the previous reports. Angiotensin-converting enzyme (ACE) in cerebro-spinal fluid not only raised on exacerbation also lowered with improvement of symptoms after steroid therapy. The ACE, which had a selective activity in the central nervous system, seemed to contribute to the index of treatment for sarcoidosis.
Kugi
M
M
First Department of Internal Medicine, Faculty of Medicine, Fukuoka University.
Kawanami
S
S
Mori
S
S
Nakane
K
K
Nishimaru
K
K
D000368:Aged; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage; D015415:Biomarkers / Q000134:cerebrospinal fluid; D003389:Cranial Nerve Diseases / Q000150:complications* / Q000188:drug therapy; D005260:Female; D006801:Humans; D009443:Neuritis / Q000150:complications* / Q000188:drug therapy; D007703:Peptidyl-Dipeptidase A / Q000134:cerebrospinal fluid; D010523:Peripheral Nervous System Diseases / Q000150:complications* / Q000188:drug therapy; D011115:Polyneuropathies / Q000150:complications* / Q000188:drug therapy; D011239:Prednisolone / Q000008:administration & dosage; D012507:Sarcoidosis / Q000150:complications* / Q000188:drug therapy
D000893:Anti-Inflammatory Agents; D015415:Biomarkers; D011239:Prednisolone; D007703:Peptidyl-Dipeptidase A